Bionime Corp
TWSE:4737
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.45
80
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| TW |
|
Bionime Corp
TWSE:4737
|
4B TWD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.8B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
129.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD |
Loading...
|
Market Distribution
| Min | -21 347.1% |
| 30th Percentile | 0.7% |
| Median | 5% |
| 70th Percentile | 11.5% |
| Max | 698% |
Other Profitability Ratios
Bionime Corp
Glance View
Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company is headquartered in Taichung, Taichung. The company went IPO on 2009-08-26. The firm's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The firm distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Bionime Corp is -6.8%, which is below its 3-year median of -2.1%.
Over the last 3 years, Bionime Corp’s Operating Margin has decreased from 5.5% to -6.8%. During this period, it reached a low of -8.4% on Mar 31, 2025 and a high of 5.9% on Dec 31, 2022.